Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Dow
AstraZeneca
US Department of Justice
QuintilesIMS
McKinsey
Daiichi Sankyo
Teva
Colorcon

Generated: May 23, 2018

DrugPatentWatch Database Preview

MYKACET Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Mykacet patents expire, and when can generic versions of Mykacet launch?

Mykacet is a drug marketed by G And W Labs Inc and is included in two NDAs.

The generic ingredient in MYKACET is nystatin; triamcinolone acetonide. There are eight drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the nystatin; triamcinolone acetonide profile page.
Summary for MYKACET
Drug patent expirations by year for MYKACET
Pharmacology for MYKACET

US Patents and Regulatory Information for MYKACET

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
G And W Labs Inc MYKACET nystatin; triamcinolone acetonide CREAM;TOPICAL 062367-001 May 28, 1985 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
G And W Labs Inc MYKACET nystatin; triamcinolone acetonide OINTMENT;TOPICAL 062733-001 Mar 6, 1987 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Fish and Richardson
Chubb
McKesson
Farmers Insurance
QuintilesIMS
Express Scripts
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.